Connect with us

Register now for MAAPC & MACNS Pharmacology Update 2024, Saturday, April 6, 2024. Why? Do you know how to use biologics and other new treatments in COPD?

Posted about 1 month ago by Elaine Crain

Farzana Musawwir PharmD RPh BCPS - Updates in COPD (including biologics)

Farzana Musawwir, PharmD, RPh, BCPS, is a highly accomplished healthcare professional serving as a Clinical Pharmacy Specialist at the University of Maryland Medical Center (UMMC). With expertise in COPD management, she has made significant contributions to patient safety, health outcomes, and healthcare cost efficiency.

Farzana has been actively involved in the management of patients with COPD, focusing on delivering comprehensive medication management and clinical support. Her responsibilities include ensuring medication access, promoting adherence, and providing crucial clinical support through pharmacological interventions. This involves the selection of appropriate drugs and doses, identification of potential side effects and drug interactions, and offering counseling to patients and teaching to the healthcare team. Her dedication to teaching and counseling aligns with the goal of improving patient outcomes and enhancing the quality of care provided to individuals with COPD.

One of Farzana's notable achievements is her role in the establishment of guidelines and workflow structures for transitional care ambulatory pharmacy services at UMMC. This initiative reflects her commitment to improving the continuity of care for patients, a crucial aspect in managing chronic conditions such as COPD. By contributing to the development of guidelines, she has played a pivotal role in ensuring standardized and evidence-based approaches to medication management in transitional care settings.

Furthermore, her involvement in the Critical Care Pharmacy Service at the University of Maryland Baltimore Washington Medical Center underscores her commitment to enhancing medication safety and patient outcomes. Farzana pioneered the establishment of the first bedside care clinical pharmacy service in the critical care unit, ensuring a proactive approach to medication management for critically ill patients. This experience equips her with valuable insights into managing complex cases, including those involving COPD exacerbations in critical care settings.

Active contribution in multidisciplinary committees, such as the Sepsis Committee, showcases Farzana's dedication to advancing healthcare practices. As a Clinical Assistant Professor, she plays a crucial role in shaping the future of pharmacy professionals, mentoring residents in their pursuit of excellence in healthcare. Farzana's presentations and publications on pharmacy practice topics highlight her commitment to knowledge sharing.

In addition to her clinical and educational roles, Farzana has presented and published on various topics related to pharmacy practice. Her presentations on pain-agitation delirium management in the intensive care unit and antibiotic stewardship trends showcase her commitment to sharing knowledge and contributing to advancements in pharmacy practice.

In summary, Farzana Musawwir's extensive experience, from establishing critical care pharmacy services to contributing to guideline development, positions her as a seasoned expert in COPD management. Her multifaceted roles in clinical practice, education, and research make her a valuable resource for insights, best practices, and advancements in the field of pharmaceutical care for individuals with COPD

Register Now!

Rachel Sherman, DNP, CRNP, FNP-BC, ACHPN—Pharmacology Trends in Hospice & Palliative Care


Jill Burgholzer, DNP, CRNP-PMH, FNP & Kamala Via, DNP, CRNP-PMH—Bridging the Gap in Mental Health Care: Considerations for PCPs Treating Depression, Anxiety and Sleep Disturbances


Theresa Chea, PharmD, BCPS ,– Sugar, how do you get so high? Pharmacological approaches to Diabetes Mellitus


Jane Kapustin, PhD, CRNP, BC-ADM, FAANP, FAAN—Using Continuous Glucose Monitoring (CGM) to Optimize Diabetes Outcomes


Ahmed Eid, PharmD, BCPS—Pharmacological Management of Select Cardiovascular Diseases (including biologics)


Farzana Musawwir, PharmD, BCPS—Updates in COPD (including biologics)


Lisa Yager, MSN, CRNP, A-GPCNP—Deep Vein Thrombosis (DVT): Clinical Presentation, Diagnosing, Treatment & More

Attached is a flyer to share with your colleagues and friends – all are welcome!    

Consider becoming a member of your professional organization today and keep our profession vibrant & essential

(MAAPC) (MACNS)

Thank you to our Industry and Pharmaceutical partners who continue to provide us with up-to-date information, new products, and practice information (Click logos for more information).

https://www.skyrizihcp.com

https://www.rinvoqhcp.com
























MAAPC is also offering on-line presentations that meet the requirements for new and renewing licensure.

CDS Requirement: Safe Prescribing of Opioids & Consolidated Appropriations Act of 2023

These presentations meet Maryland’s 2018 requirement for applicants registering for new or renewing CDS registration (Safe Prescribing of Opioids) and the Consolidated Appropriations Act of 2023, and provide 6 CE hours of pharmacology for recertification.

Implicit Bias Training

Beginning April 1, 2022, when you apply for a Maryland health occupation license or complete your renewal application, you will be required to attest that you have completed an approved implicit bias training course. This applies to all “health care professionals” (physician, nurse, dentist, social worker, psychologist, pharmacist, health educator, or other allied health professional). You are NOT required to submit a certificate of completion for this training to your Board and Continuing Education Units (CEUs) are NOT required, however MAAPC provides a certificate of completion if needed.